Found: 107
Select item for more details and to access through your institution.
Pearls in Mitigating Application Pain of Topical Nonsteroidal Agents.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dupilumab and Alopecia: Causative or Therapeutic?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of crisaborole in patients with mild-tomoderate atopic dermatitis and other atopic comorbidities.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 5, p. 425, doi. 10.2500/aap.2021.42.210064
- By:
- Publication type:
- Article
Complementary and Alternative Therapies for Psoriasis.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 8, p. 1, doi. 10.1007/s00403-024-03279-4
- By:
- Publication type:
- Article
Topical steroids or emollients: does order matter?
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 4, p. 1, doi. 10.1007/s00403-024-02837-0
- By:
- Publication type:
- Article
Identifying prevalence and inpatient outcomes of anemia and hidradenitis suppurativa.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 5, p. 1287, doi. 10.1007/s00403-022-02515-z
- By:
- Publication type:
- Article
Myths and media in oral collagen supplementation for the skin, nails, and hair: A review.
- Published in:
- Journal of Cosmetic Dermatology, 2022, v. 21, n. 2, p. 438, doi. 10.1111/jocd.14567
- By:
- Publication type:
- Article
A new era of moisturizers.
- Published in:
- Journal of Cosmetic Dermatology, 2021, v. 20, n. 8, p. 2425, doi. 10.1111/jocd.14217
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 5, p. 526, doi. 10.1001/jamadermatol.2023.0391
- By:
- Publication type:
- Article
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic Review.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 3, p. 320, doi. 10.1001/jamadermatol.2022.6045
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Considerations in Weaning or Withdrawing Dupilumab Therapy-Nothing Is Forever.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Learning About Dupilumab-Associated Conjunctivitis-Reply.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association of Atherosclerosis Prevalence With Age, Race, and Traditional Risk Factors in Patients With Psoriasis.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Management.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 9, p. 1009, doi. 10.1001/jamadermatol.2015.0250
- By:
- Publication type:
- Article
Improving Patient Education With an Eczema Action Plan: A Randomized Controlled Trial.
- Published in:
- JAMA Dermatology, 2013, v. 149, n. 4, p. 481, doi. 10.1001/jamadermatol.2013.2143
- By:
- Publication type:
- Article
A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis.
- Published in:
- Drugs in R&D, 2019, v. 19, n. 4, p. 311, doi. 10.1007/s40268-019-00288-x
- By:
- Publication type:
- Article
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 6, p. 755, doi. 10.1007/s40257-022-00714-y
- By:
- Publication type:
- Article
The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 1, p. 27, doi. 10.1007/s40257-021-00647-y
- By:
- Publication type:
- Article
Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2019, v. 20, n. 4, p. 565, doi. 10.1007/s40257-019-00436-8
- By:
- Publication type:
- Article
Alternative Treatments for Atopic Dermatitis: An Update.
- Published in:
- American Journal of Clinical Dermatology, 2019, v. 20, n. 2, p. 251, doi. 10.1007/s40257-018-0412-3
- By:
- Publication type:
- Article
Complementary and Alternative Medicine for Atopic Dermatitis: An Evidence-Based Review.
- Published in:
- American Journal of Clinical Dermatology, 2016, v. 17, n. 6, p. 557, doi. 10.1007/s40257-016-0209-1
- By:
- Publication type:
- Article
Non-Pharmacologic Therapies for Atopic Dermatitis.
- Published in:
- Current Allergy & Asthma Reports, 2013, v. 13, n. 5, p. 528, doi. 10.1007/s11882-013-0371-y
- By:
- Publication type:
- Article
Dietary Triggers for Atopic Dermatitis in Children.
- Published in:
- Cutis, 2022, v. 110, n. 5, p. 264, doi. 10.12788/cutis.0640
- By:
- Publication type:
- Article
Patch Testing on Dupilumab: Reliable or Not?
- Published in:
- Cutis, 2022, v. 109, n. 3, p. 158, doi. 10.12788/cutis.0471
- By:
- Publication type:
- Article
Assessing the effects of topical cannabidiol in patients with atopic dermatitis.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Photobiomodulation therapy and low-level light therapy in wound healing.
- Published in:
- Lasers in Medical Science, 2023, v. 38, n. 1, p. 1, doi. 10.1007/s10103-023-03909-9
- By:
- Publication type:
- Article
Effects of sun protection on serum vitamin D deficiency.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2023, v. 39, n. 4, p. 394, doi. 10.1111/phpp.12838
- By:
- Publication type:
- Article
Acupuncture in Dermatology: An Update to a Systematic Review.
- Published in:
- Journal of Alternative & Complementary Medicine, 2021, v. 27, n. 1, p. 12, doi. 10.1089/acm.2020.0230
- By:
- Publication type:
- Article
The Role of Polyphenols in Rosacea Treatment: A Systematic Review.
- Published in:
- Journal of Alternative & Complementary Medicine, 2017, v. 23, n. 12, p. 920, doi. 10.1089/acm.2016.0398
- By:
- Publication type:
- Article
Impact of atopic dermatitis lesion locations and extent on patient burden: A real‐world study.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 4, p. 1061, doi. 10.1002/jvc2.413
- By:
- Publication type:
- Article
Atopic eczema patients and healthcare professionals join forces in Malta.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 404, doi. 10.1002/jvc2.156
- By:
- Publication type:
- Article
Pandemic Pressure: Teledermatology and Health Care Disparities.
- Published in:
- Journal of Patient Experience, 2021, v. 8, p. 1, doi. 10.1177/2374373521996982
- By:
- Publication type:
- Article
Pandemic Pressure: Teledermatology and Health Care Disparities.
- Published in:
- Journal of Patient Experience, 2021, v. 8, p. 1, doi. 10.1177/2374373521996982
- By:
- Publication type:
- Article
Digital imaging in dermatology: attitudes, behaviors, and innovations.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2249, doi. 10.1007/s13555-024-01226-9
- By:
- Publication type:
- Article
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2171, doi. 10.1007/s13555-024-01225-w
- By:
- Publication type:
- Article
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1929, doi. 10.1007/s13555-024-01199-9
- By:
- Publication type:
- Article
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1337, doi. 10.1007/s13555-022-00731-z
- By:
- Publication type:
- Article
Biologics and Small Molecule Inhibitors: an Update in Therapies for Allergic and Immunologic Skin Diseases.
- Published in:
- Current Allergy & Asthma Reports, 2022, v. 22, n. 12, p. 183, doi. 10.1007/s11882-022-01047-w
- By:
- Publication type:
- Article
Biologics for Allergic Dermatologic Diseases.
- Published in:
- Current Allergy & Asthma Reports, 2020, v. 20, n. 8, p. 1, doi. 10.1007/s11882-020-00923-7
- By:
- Publication type:
- Article
Alternative, Complementary, and Forgotten Remedies for Atopic Dermatitis.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2015, v. 2015, p. 1, doi. 10.1155/2015/676897
- By:
- Publication type:
- Article
Integrative Approaches to Sleep Management in Skin Disease: Systematic Review.
- Published in:
- JMIR Dermatology, 2023, v. 6, n. 1, p. 478, doi. 10.2196/48713
- By:
- Publication type:
- Article
Atopic Dermatitis: Beyond the Skin and Into the Gut.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 17, p. 5534, doi. 10.3390/jcm12175534
- By:
- Publication type:
- Article
627 - A checklist to aid in identifying patients with atopic dermatitis who are candidates for systemic therapy.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.011
- By:
- Publication type:
- Article
Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 6, p. 917, doi. 10.1093/bjd/ljae056
- By:
- Publication type:
- Article
Tralokinumab real-world patient-reported outcomes in moderate-to-severe atopic dermatitis adult patients in the United States: 6-month interim analysis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii50, doi. 10.1093/bjd/ljad498.052
- By:
- Publication type:
- Article
Lebrikizumab in combination with topical corticosteroids maintains improvements in itch and sleep at 68 weeks in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii6, doi. 10.1093/bjd/ljad498.008
- By:
- Publication type:
- Article
Conjunctivitis does not increase with longer duration of lebrikizumab exposure in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii5, doi. 10.1093/bjd/ljad498.007
- By:
- Publication type:
- Article